Clinical Value of CA19-9, Contrast-Enhanced MRI and PET-CT in the Diagnosis and Staging of Pancreatic Cancer

doi:10.11748/bjmy.issn.1006-1703.2014.05.004

PDF(1007 KB)

Labeled Immunoassays and Clinical Medicine ›› 2014, Vol. 21 ›› Issue (5) : 507. DOI: 10.11748/bjmy.issn.1006-1703.2014.05.004

Clinical Value of CA19-9, Contrast-Enhanced MRI and PET-CT in the Diagnosis and Staging of Pancreatic Cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2014, 21(5): 507 https://doi.org/10.11748/bjmy.issn.1006-1703.2014.05.004

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(1007 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2014-06-11	2014-07-11	2014-10-25
Issue Date
2014-11-06

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS